{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T23:50:09Z","timestamp":1786751409875,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001501","name":"UGC","doi-asserted-by":"publisher","award":["Ref: No. 20-12\/2009(ii)EU-IV dated 8.4.2011"],"award-info":[{"award-number":["Ref: No. 20-12\/2009(ii)EU-IV dated 8.4.2011"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.vaccine.2015.04.030","type":"journal-article","created":{"date-parts":[[2015,4,27]],"date-time":"2015-04-27T21:16:47Z","timestamp":1430169407000},"page":"2786-2792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Recombinant L7\/L12 protein entrapping PLGA (poly lactide-co-glycolide) micro particles protect BALB\/c mice against the virulent B. abortus 544 infection"],"prefix":"10.1016","volume":"33","author":[{"given":"Damini","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.04.030_bib0220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1574891X11308010006","article-title":"Brucella as a potential agent of bioterrorism","volume":"8","author":"Doganay","year":"2013","journal-title":"Recent Patents Anti-Infect Drug Disc"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0225","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1128\/jb.172.7.3569-3576.1990","article-title":"Brucella abortus 16S rRNA and lipid A reveal a phylogenetic relationship with members of the alpha-2 subdivision of the class Proteobacteria","volume":"172","author":"Moreno","year":"1990","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0230","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1615\/CritRevImmunol.v26.i5.30","article-title":"Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection","volume":"26","author":"Baldwin","year":"2006","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0235","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-1135(02)00253-5","article-title":"Epidemiology, zoonotic aspects, vaccination and control\/eradication of brucellosis in India","volume":"90","author":"Renukaradhya","year":"2002","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0240","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1051\/vetres:2005003","article-title":"From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis","volume":"36","author":"Godfroid","year":"2005","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0245","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1086\/378125","article-title":"Brucellosis and the respiratory system","volume":"37","author":"Pappas","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0250","first-page":"395","article-title":"Clinical aspects of brucellosis. VI. Respiratory system","volume":"28","author":"Veiga","year":"1971","journal-title":"Rev Bras Med"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0255","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1128\/IAI.69.7.4528-4535.2001","article-title":"Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells","volume":"69","author":"Briones","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0260","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/vr.101979","article-title":"Comparison of depopulation and S19-RB51 vaccination strategies for control of bovine brucellosis in high prevalence areas","volume":"174","author":"Saez","year":"2014","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1051\/vetres:2003037","article-title":"Rough vaccines in animal brucellosis: structural and genetic basis and present status","volume":"35","author":"Moriyon","year":"2004","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0270","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0021-9975(67)90021-7","article-title":"Effect of living Rev. 1 vaccine in producing long-term immunity against Brucella melitensis infection in sheep in Iran","volume":"77","author":"Entessar","year":"1967","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0275","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0034-5288(18)34424-2","article-title":"Vaccination of guinea-pigs with rev. I Brucella melitensis vaccine. The response to very large and very small doses","volume":"10","author":"Alton","year":"1969","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0280","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/dna.2006.0552","article-title":"A combined DNA vaccine encoding BCSP31, SOD, and L7\/L12 confers high protection against Brucella abortus 2308 by inducing specific CTL responses","volume":"26","author":"Yu","year":"2007","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0285","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.vaccine.2006.12.004","article-title":"Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization","volume":"25","author":"Yang","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0290","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1128\/IAI.62.12.5361-5366.1994","article-title":"Brucella ribosomal protein L7\/L12 is a major component in the antigenicity of brucellin INRA for delayed-type hypersensitivity in brucella-sensitized guinea pigs","volume":"62","author":"Bachrach","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0295","first-page":"395","article-title":"Biological control of the brucellin INRA in sensitized guinea pigs: a guide for the statistical analysis of results","volume":"15","author":"de Reviers","year":"1984","journal-title":"Ann Rech Vet"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0300","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/infdis\/106.1.106","article-title":"The in vitro sensitivity to brucellergen of leucocytes from guinea pigs experimentally infected with Brucella abortus","volume":"106","author":"Darlington","year":"1960","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0305","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ejpb.2007.09.006","article-title":"Controlled release of PEI\/DNA complexes from PLGA microspheres as a potent delivery system to enhance immune response to HIV vaccine DNA prime\/MVA boost regime","volume":"68","author":"Zhou","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0310","first-page":"217","article-title":"Poly(d,l-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination","volume":"10","author":"Wang","year":"2007","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0315","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1128\/IAI.63.10.3945-3952.1995","article-title":"Surface exposure of outer membrane protein and lipopolysaccharide epitopes in Brucella species studied by enzyme-linked immunosorbent assay and flow cytometry","volume":"63","author":"Bowden","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0320","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.vaccine.2012.12.043","article-title":"Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544","volume":"31","author":"Goel","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0325","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molimm.2012.02.126","article-title":"Intradermal immunization with outer membrane protein 25 protects Balb\/c mice from virulent B. abortus 544","volume":"51","author":"Goel","year":"2012","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0330","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1128\/AAC.00524-10","article-title":"Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation","volume":"55","author":"Banerjee","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0335","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1128\/IAI.59.9.2978-2986.1991","article-title":"Biodegradable and biocompatible poly(dl-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies","volume":"59","author":"Eldridge","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0340","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/0264-410X(95)00084-E","article-title":"Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38kDa protein entrapped in biodegradable PLG microparticles","volume":"13","author":"Vordermeier","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0345","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0939-6411(00)00079-5","article-title":"Revisiting PLA\/PLGA microspheres: an analysis of their potential in parenteral vaccination","volume":"50","author":"Johansen","year":"2000","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0350","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4110\/in.2013.13.1.30","article-title":"Induction of potent antigen-specific cytotoxic T cell response by PLGA-nanoparticles containing antigen and TLR agonist","volume":"13","author":"Lee","year":"2013","journal-title":"Immune Network"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0355","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0168-3659(98)00116-3","article-title":"PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug","volume":"57","author":"Govender","year":"1999","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0360","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/jbm.10019","article-title":"Uptake of poly(d,l-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo","volume":"60","author":"Newman","year":"2002","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0365","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jconrel.2011.01.005","article-title":"Microencapsulation of inorganic nanocrystals into PLGA microsphere vaccines enables their intracellular localization in dendritic cells by electron and fluorescence microscopy","volume":"151","author":"Schliehe","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0370","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.addr.2007.04.007","article-title":"Solid lipid nanoparticles as a drug delivery system for peptides and proteins","volume":"59","author":"Almeida","year":"2007","journal-title":"Adv Drug Delivery Rev"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0375","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1365-2567.2001.01258.x","article-title":"Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL\/6 and susceptible BALB\/c mice","volume":"103","author":"Murphy","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0380","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/intimm\/5.8.877","article-title":"Brucella abortus induces a novel cytokine gene expression pattern characterized by elevated IL-10 and IFN-gamma in CD4+ T cells","volume":"5","author":"Svetic","year":"1993","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0385","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0065-2776(08)60405-8","article-title":"Confrontation between intracellular bacteria and the immune system","volume":"71","author":"Schaible","year":"1999","journal-title":"Adv Immunol"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0390","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1371\/journal.pone.0000631","article-title":"Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection","volume":"2","author":"Barquero-Calvo","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0395","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.4049\/jimmunol.161.3.1447","article-title":"Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors","volume":"161","author":"Zhan","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0400","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1128\/IAI.00761-12","article-title":"Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B, cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice","volume":"80","author":"Vitry","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0405","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1128\/IAI.64.7.2782-2786.1996","article-title":"Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms","volume":"64","author":"Zhan","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0410","doi-asserted-by":"crossref","first-page":"137","DOI":"10.20506\/rst.32.1.2190","article-title":"Immunity to brucellosis","volume":"32","author":"Skendros","year":"2013","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0415","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1128\/IAI.05080-11","article-title":"Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses","volume":"79","author":"Clapp","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0420","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0092-8674(88)90486-2","article-title":"A novel form of TNF\/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF","volume":"53","author":"Kriegler","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0425","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.4049\/jimmunol.143.12.4034","article-title":"Evidence for the existence of two forms of membrane tumor necrosis factor: an integral protein and a molecule attached to its receptor","volume":"143","author":"Luettig","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.04.030_bib0430","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1016\/j.vaccine.2007.01.066","article-title":"Liposomised recombinant ribosomal L7\/L12 protein protects BALB\/c mice against Brucella abortus 544 infection","volume":"25","author":"Mallick","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15004946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15004946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T20:59:11Z","timestamp":1691614751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15004946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":43,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0264410X15004946"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.030","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant L7\/L12 protein entrapping PLGA (poly lactide-co-glycolide) micro particles protect BALB\/c mice against the virulent B. abortus 544 infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}